194 related articles for article (PubMed ID: 36864577)
21. The role of N-glycans in colorectal cancer progression: potential biomarkers and therapeutic applications.
de Freitas Junior JC; Morgado-Díaz JA
Oncotarget; 2016 Apr; 7(15):19395-413. PubMed ID: 26539643
[TBL] [Abstract][Full Text] [Related]
22. Glycosylation and Integrin Regulation in Cancer.
Marsico G; Russo L; Quondamatteo F; Pandit A
Trends Cancer; 2018 Aug; 4(8):537-552. PubMed ID: 30064662
[TBL] [Abstract][Full Text] [Related]
23. Glycans as cancer biomarkers.
Adamczyk B; Tharmalingam T; Rudd PM
Biochim Biophys Acta; 2012 Sep; 1820(9):1347-53. PubMed ID: 22178561
[TBL] [Abstract][Full Text] [Related]
24. A serum glycomics approach to breast cancer biomarkers.
Kirmiz C; Li B; An HJ; Clowers BH; Chew HK; Lam KS; Ferrige A; Alecio R; Borowsky AD; Sulaimon S; Lebrilla CB; Miyamoto S
Mol Cell Proteomics; 2007 Jan; 6(1):43-55. PubMed ID: 16847285
[TBL] [Abstract][Full Text] [Related]
25. MALDI Mass Spectrometry Imaging of N-Linked Glycans in Cancer Tissues.
Drake RR; Powers TW; Jones EE; Bruner E; Mehta AS; Angel PM
Adv Cancer Res; 2017; 134():85-116. PubMed ID: 28110657
[TBL] [Abstract][Full Text] [Related]
26. Abnormal Glycosylation in Cancer Cells and Cancer Stem Cells as a Therapeutic Target.
Quader S; Tanabe S; Cabral H
Adv Exp Med Biol; 2022; 1393():141-156. PubMed ID: 36587306
[TBL] [Abstract][Full Text] [Related]
27. Circular RNAs and their participation in stemness of cancer.
Lagunas-Rangel FA
Med Oncol; 2020 Apr; 37(5):42. PubMed ID: 32266486
[TBL] [Abstract][Full Text] [Related]
28. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
29. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
30. Glycan-specific antibodies as potential cancer biomarkers: a focus on microarray applications.
Tikhonov A; Smoldovskaya O; Feyzkhanova G; Kushlinskii N; Rubina A
Clin Chem Lab Med; 2020 Sep; 58(10):1611-1622. PubMed ID: 32324152
[TBL] [Abstract][Full Text] [Related]
31.
Conroy LR; Stanback AE; Young LEA; Clarke HA; Austin GL; Liu J; Allison DB; Sun RC
Mol Cancer Res; 2021 Oct; 19(10):1727-1738. PubMed ID: 34131069
[TBL] [Abstract][Full Text] [Related]
32. An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation.
Shin KH; Kim RH
Crit Rev Oncog; 2018; 23(3-4):189-200. PubMed ID: 30311574
[TBL] [Abstract][Full Text] [Related]
33. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
34. Altered glycosylation in tumours focused to cancer diagnosis.
Peracaula R; Barrabés S; Sarrats A; Rudd PM; de Llorens R
Dis Markers; 2008; 25(4-5):207-18. PubMed ID: 19126965
[TBL] [Abstract][Full Text] [Related]
35. Isolation, identification, and characterization of cancer stem cells: A review.
Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
[TBL] [Abstract][Full Text] [Related]
36. Glycosylation in the Era of Cancer-Targeted Therapy: Where Are We Heading?
Mereiter S; Balmaña M; Campos D; Gomes J; Reis CA
Cancer Cell; 2019 Jul; 36(1):6-16. PubMed ID: 31287993
[TBL] [Abstract][Full Text] [Related]
37. O-glycan recognition and function in mice and human cancers.
Cervoni GE; Cheng JJ; Stackhouse KA; Heimburg-Molinaro J; Cummings RD
Biochem J; 2020 Apr; 477(8):1541-1564. PubMed ID: 32348475
[TBL] [Abstract][Full Text] [Related]
38. N-glycosylation Profiling of Colorectal Cancer Cell Lines Reveals Association of Fucosylation with Differentiation and Caudal Type Homebox 1 (CDX1)/Villin mRNA Expression.
Holst S; Deuss AJ; van Pelt GW; van Vliet SJ; Garcia-Vallejo JJ; Koeleman CA; Deelder AM; Mesker WE; Tollenaar RA; Rombouts Y; Wuhrer M
Mol Cell Proteomics; 2016 Jan; 15(1):124-40. PubMed ID: 26537799
[TBL] [Abstract][Full Text] [Related]
39. Cancer Stem Cell Hypothesis for Therapeutic Innovation in Clinical Oncology? Taking the Root Out, Not Chopping the Leaf.
Dzobo K; Senthebane DA; Rowe A; Thomford NE; Mwapagha LM; Al-Awwad N; Dandara C; Parker MI
OMICS; 2016 Dec; 20(12):681-691. PubMed ID: 27930094
[TBL] [Abstract][Full Text] [Related]
40. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.
Hakomori S
Cancer Res; 1996 Dec; 56(23):5309-18. PubMed ID: 8968075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
